about
Gene therapy on the moveFlow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary ImmunodeficienciesMolecular mechanisms of retroviral integration site selection.Genetic barcode sequencing for screening altered population dynamics of hematopoietic stem cells transduced with lentivirusThe case for newborn screening for severe combined immunodeficiency and related disordersCharacterization of Equine Infectious Anemia Virus Integration in the Horse GenomeIn vivo selection of autologous MGMT gene-modified cells following reduced-intensity conditioning with BCNU and temozolomide in the dog modelBET proteins promote efficient murine leukemia virus integration at transcription start sites.Strategies for more rapid translation of cellular therapies for children: a US perspective.Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line.Screening for severe combined immunodeficiency in neonates.The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901.Evidence of innate lymphoid cell redundancy in humans.Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.Neonatal screening for severe combined immunodeficiencyTargeting co-stimulatory pathways in gene therapyAdvances in basic and clinical immunology in 2011.Emerging uses for pediatric hematopoietic stem cells.Lentiviral vectors for cutaneous RNA managing.Targeted gene therapies: tools, applications, optimizationThe role of induced pluripotent stem cells in research and therapy of primary immunodeficiencies.Self-renewal of thymocytes in the absence of competitive precursor replenishment.Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation.50 years of pediatric immunology: progress and future, a clinical perspective.Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles.The γ c family of cytokines: fine-tuning signals from IL-2 and IL-21 in the regulation of the immune response.Genome-wide Mapping of Off-Target Events in Single-Stranded Oligodeoxynucleotide-Mediated Gene Repair Experiments.F2A sequence linking MGMT(P140K) and MDR1 in a bicistronic lentiviral vector enables efficient chemoprotection of haematopoietic stem cells.Osteopetrosis rescue upon RANKL administration to Rankl(-/-) mice: a new therapy for human RANKL-dependent ARO.
P2860
Q27007012-5DB3C571-C657-45C1-A30C-324E19F2C8AAQ28076919-0D14410D-C1D2-48CC-B5D7-69E969C3E8DCQ34249653-169F2AD4-EB99-4EDA-B04C-D1C9C1A17C31Q35655956-BA587E76-F91D-4D73-8693-4A6321E1E790Q35761004-BEFF5AF2-3556-4D8E-B2C0-F146072F37CCQ35808693-C632842C-A565-4869-8BF0-A3B88DD42460Q36303065-F8A4AF78-7826-40EB-8E50-ACEABA3FA778Q37031911-FCEBB397-5190-46FE-938A-3E3C6CE1263FQ37056225-28673E63-22A4-4AFB-A923-0A51877A67DCQ37066362-E36C15AF-C942-431F-8A95-746E7712A7C3Q37196045-8F9AC78C-473D-4318-8BAD-F3DB57EB66A8Q37201035-847BE9F3-A599-41F4-8F80-E967FCD0E89CQ37357543-488E192C-0436-4BD1-949B-79376CAE874BQ37734367-C7207365-C259-44A9-B6F5-83B7279397ACQ37946150-9C1A9651-7C35-4A75-8D9B-9569506C3E51Q37951935-438C253E-6CE0-4734-A433-0D47F0C44B7EQ37972191-3A31A558-EE16-4EBE-880B-5F33CD13FD9BQ37978779-EBB16280-3FA2-42F9-9FD8-A3A750C65EC3Q37989486-DD371B66-DC68-452E-AE4C-AEF0C57C8409Q38005211-EE69418C-CE83-4604-816D-FFD189E2976CQ38030196-4C69A37E-AB63-4D9C-AF17-093EADABAB65Q38031217-6AB9B246-887E-40CD-B41E-837CB8F5602FQ38420971-405E90D6-BC7A-44AC-AD39-B8B79B07FB0DQ39469918-D0A68D26-2372-49E5-B5C1-04EBDA1646D9Q42602801-ADB6D61D-8516-48CB-800E-E4535259A9CEQ45797119-A89209BF-5688-438F-885C-9AA50FC347EBQ47590940-79DCF493-1405-461A-A9B1-A8C5A6FE572AQ54289145-C166F950-B9B1-4A34-8BA3-CA2D544A0F15Q55056509-CA04E0B8-7F58-4F77-886E-7045E25B0647
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gene therapy for primary adaptive immune deficiencies.
@en
Gene therapy for primary adaptive immune deficiencies.
@nl
type
label
Gene therapy for primary adaptive immune deficiencies.
@en
Gene therapy for primary adaptive immune deficiencies.
@nl
prefLabel
Gene therapy for primary adaptive immune deficiencies.
@en
Gene therapy for primary adaptive immune deficiencies.
@nl
P50
P1476
Gene therapy for primary adaptive immune deficiencies.
@en
P304
P356
10.1016/J.JACI.2011.04.030
P407
P577
2011-06-01T00:00:00Z